OTC market: a new global leader?

Ten post jest także dostępny w języku: polski

GlaxoSmithKline (GSK) and Pfizer, global pharmaceutical companies, will join forces. In mid-2019, a joint venture will be established, whose main area of operation will be the OTC market (over-the-counter products).

GSK will have a majority share in the new venture – 68%. Pfizer will receive 32% of the shares. Their portfolio will include OTC drugs (including analgesics), vitamins, minerals and supplements, oral care and skin protection products, as well as digestion enhancing products.

Additionally, as a result of this undertaking, the cost synergy will amount to $650 million.  The company is planned to be separated in the future, but only GSK will have the right to make this decision.

To sum up, it may mean that the global OTC market will have a new leader. The annual sales of products in the portfolio of the new company amounted to 2017. USD 12.7bn.

Similar Posts

One Comment

  1. I lost my Job few months ago,my wife left me ,could not get income for my family, things was so tough and I couldn’t get anything for my children, not until a met a recommendation on a page writing how Mr Bernie Wilfred helped a lady in getting a huge amount of profit every 6 working days on trading with his management on the cryptocurrency Market, to be honest I never believe it but I took the risk to take a loan of $2000. and I contacted him unbelievable and I was so happy I earn $22,500 in 6 working days, the most joy is that I can now take care of my family I don’t know how to appreciate your good work Mr. Bernie Doran God will continue to bless you for being a life saver I have no way to appreciate you than to tell people about your good trade management system. 
For a perfect investment and good strategies contact Mr Bernie Doran via WhatsApp :+1(424)285-0682 or Telegram : @Bernie_fx or Gmail : Bernie.doranfx01@gmail.com

Leave a Reply

Your email address will not be published. Required fields are marked *